PaulDiSilvestroMD
Obstetrics & Gynecology • Providence, RIGeneral Obstetrics, Gynecologic Oncology
Associate Professor, Obstetrics and Gynecology, Brown University Program in Medicine
Dr. DiSilvestro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Dudley St
Providence, RI 02905Phone+1 401-453-7520- Is this information wrong?
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology, 1996 - 1999
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 1990 - 1994
University of Vermont College of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1996 - 2024
CT State Medical License 2003 - 2024
RI State Medical License 1991 - 2024
NY State Medical License 1999 - 2004
OK State Medical License 1996 - 1999- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer Start of enrollment: 2006 Feb 01
- Doxil and Gemcitabine in Recurrent Ovarian Cancer Start of enrollment: 2006 Apr 01
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.Lilian T Gien, Danielle M Enserro, Linda R Duska, Andrea E Wahner-Hendrickson, Premal H Thaker, Allan Covens, Kathleen N Moore, Robert L Coleman, Matthew S Block, Stev...> ;Gynecologic Oncology. 2024 Apr 10
- Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/EN...Pothuri, B., Han, S., Chase, D., Heitz, F., Burger, R., Gaba, L., Van Le, L., Guerra, E., Bender, D., Korach, J., Cloven, N., Churruca, C., Follana, P., DiSilvestro, P...> ;Gynecologic Oncology. 2024 Feb 6
- 7 citationsLifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of di...Cynthia A Thomson, Tracy E Crane, Austin Miller, Michael A Gold, Matthew Powell, Kristin Bixel, Linda Van Le, Paul DiSilvestro, Elena Ratner, Shashikant Lele, Saketh G...> ;Gynecologic Oncology. 2023 Mar 1
- Join now to see all
Journal Articles
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian CancerKathleen Moore, Paul DiSilvestro, Carol Aghajanian, The New England Journal of Medicine
Other
- Adjuvant treatment of high-risk endometrial cancersDiSilvestro PA, Fleming G
http://www.uptodate.com/contents/adjuvant-treatment-of-high-risk-endometrial-cancers
UpToDate, Wolters Kluwer Health - 2012-11-13
Press Mentions
- SORAYA Analysis Highlights Mirvetuximab Soravtansine’s Value in ClinicMarch 25th, 2023
The Challenges with Using Targeted Therapies in Ovarian Cancer SpaceMarch 25th, 2023- Key Advances and Advocacy Are Themes at SGO Annual MeetingMarch 21st, 2023
- Join now to see all
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Women & Infants Hospital of Rhode IslandProvidence, Rhode Island- Milford Regional Medical CenterMilford, Massachusetts
Lawrence + Memorial HospitalNew London, Connecticut
Kent HospitalWarwick, Rhode Island
Miriam HospitalProvidence, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
